APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pet Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Pet Vaccine Market Analysis and Forecast 2026-2032

20 December 2025209 pages

Choose your research edition.

Industry ResearchPet Vaccine Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Pet Vaccine Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Pet Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pet Vaccine Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Pet Vaccine Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Pet Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Pet Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Pet Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Pet Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Pet Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Pet Vaccine include CAHIC, Zoetis, Ringpu, Merck Animal Health, Keqian Biology, Jinyu Group, Virbac, Vetoquinol and Parnell, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Pet Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Pet Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Pet Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pet Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pet Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Pet Vaccine sales, projected growth trends, production technology, application and end-user industry.

Pet Vaccine Segment by Company

CAHIC

Zoetis

Ringpu

Merck Animal Health

Keqian Biology

Jinyu Group

Virbac

Vetoquinol

Parnell

Ouro Fino Saude

Meiji

Kyoritsu Seiyaku

Elanco Animal Health

Dechra Veterinary Products

Ceva

Boehringer Ingelheim

Animalcare Group

Pet Vaccine Segment by Type

Nasal Administration

Injection

Other

Pet Vaccine Segment by Application

Cat

Dog

Other

Pet Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pet Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pet Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pet Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Pet Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Pet Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pet Vaccine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pet Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Nasal Administration Major Manufacturers Table 3. Injection Major Manufacturers Table 4. Other Major Manufacturers Table 5. Global Pet Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Cat Major Manufacturers Table 7. Dog Major Manufacturers Table 8. Other Major Manufacturers Table 9. Pet Vaccine Industry Trends Table 10. Pet Vaccine Industry Drivers Table 11. Pet Vaccine Industry Opportunities and Challenges Table 12. Pet Vaccine Industry Restraints Table 13. Global Pet Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Pet Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Pet Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Pet Vaccine Revenue Market Share by Region (2021-2026) Table 17. Global Pet Vaccine Revenue Market Share by Region (2027-2032) Table 18. Global Pet Vaccine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 19. Global Pet Vaccine Sales by Region (2021-2026) & (K Units) Table 20. Global Pet Vaccine Sales by Region (2027-2032) & (K Units) Table 21. Global Pet Vaccine Sales Market Share by Region (2021-2026) Table 22. Global Pet Vaccine Sales Market Share by Region (2027-2032) Table 23. Global Pet Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Pet Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Pet Vaccine Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Pet Vaccine Sales Market Share by Manufacturers (2021-2026) Table 27. Global Pet Vaccine Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Pet Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Pet Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Pet Vaccine Manufacturers, Product Type & Application Table 31. Global Pet Vaccine Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Pet Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Pet Vaccine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Pet Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Pet Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Pet Vaccine Revenue Market Share by Type (2021-2026) Table 38. Global Pet Vaccine Revenue Market Share by Type (2027-2032) Table 39. Global Pet Vaccine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 40. Global Pet Vaccine Sales by Type (2021-2026) & (K Units) Table 41. Global Pet Vaccine Sales by Type (2027-2032) & (K Units) Table 42. Global Pet Vaccine Sales Market Share by Type (2021-2026) Table 43. Global Pet Vaccine Sales Market Share by Type (2027-2032) Table 44. Global Pet Vaccine Price by Type (2021-2026) & (US$/Unit) Table 45. Global Pet Vaccine Price by Type (2027-2032) & (US$/Unit) Table 46. Global Pet Vaccine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Pet Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Pet Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Pet Vaccine Revenue Market Share by Application (2021-2026) Table 50. Global Pet Vaccine Revenue Market Share by Application (2027-2032) Table 51. Global Pet Vaccine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 52. Global Pet Vaccine Sales by Application (2021-2026) & (K Units) Table 53. Global Pet Vaccine Sales by Application (2027-2032) & (K Units) Table 54. Global Pet Vaccine Sales Market Share by Application (2021-2026) Table 55. Global Pet Vaccine Sales Market Share by Application (2027-2032) Table 56. Global Pet Vaccine Price by Application (2021-2026) & (US$/Unit) Table 57. Global Pet Vaccine Price by Application (2027-2032) & (US$/Unit) Table 58. CAHIC Company Information Table 59. CAHIC Business Overview Table 60. CAHIC Pet Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. CAHIC Pet Vaccine Product Portfolio Table 62. CAHIC Recent Development Table 63. Zoetis Company Information Table 64. Zoetis Business Overview Table 65. Zoetis Pet Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Zoetis Pet Vaccine Product Portfolio Table 67. Zoetis Recent Development Table 68. Ringpu Company Information Table 69. Ringpu Business Overview Table 70. Ringpu Pet Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Ringpu Pet Vaccine Product Portfolio Table 72. Ringpu Recent Development Table 73. Merck Animal Health Company Information Table 74. Merck Animal Health Business Overview Table 75. Merck Animal Health Pet Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Merck Animal Health Pet Vaccine Product Portfolio Table 77. Merck Animal Health Recent Development Table 78. Keqian Biology Company Information Table 79. Keqian Biology Business Overview Table 80. Keqian Biology Pet Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Keqian Biology Pet Vaccine Product Portfolio Table 82. Keqian Biology Recent Development Table 83. Jinyu Group Company Information Table 84. Jinyu Group Business Overview Table 85. Jinyu Group Pet Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Jinyu Group Pet Vaccine Product Portfolio Table 87. Jinyu Group Recent Development Table 88. Virbac Company Information Table 89. Virbac Business Overview Table 90. Virbac Pet Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Virbac Pet Vaccine Product Portfolio Table 92. Virbac Recent Development Table 93. Vetoquinol Company Information Table 94. Vetoquinol Business Overview Table 95. Vetoquinol Pet Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Vetoquinol Pet Vaccine Product Portfolio Table 97. Vetoquinol Recent Development Table 98. Parnell Company Information Table 99. Parnell Business Overview Table 100. Parnell Pet Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Parnell Pet Vaccine Product Portfolio Table 102. Parnell Recent Development Table 103. Ouro Fino Saude Company Information Table 104. Ouro Fino Saude Business Overview Table 105. Ouro Fino Saude Pet Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Ouro Fino Saude Pet Vaccine Product Portfolio Table 107. Ouro Fino Saude Recent Development Table 108. Meiji Company Information Table 109. Meiji Business Overview Table 110. Meiji Pet Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Meiji Pet Vaccine Product Portfolio Table 112. Meiji Recent Development Table 113. Kyoritsu Seiyaku Company Information Table 114. Kyoritsu Seiyaku Business Overview Table 115. Kyoritsu Seiyaku Pet Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Kyoritsu Seiyaku Pet Vaccine Product Portfolio Table 117. Kyoritsu Seiyaku Recent Development Table 118. Elanco Animal Health Company Information Table 119. Elanco Animal Health Business Overview Table 120. Elanco Animal Health Pet Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Elanco Animal Health Pet Vaccine Product Portfolio Table 122. Elanco Animal Health Recent Development Table 123. Dechra Veterinary Products Company Information Table 124. Dechra Veterinary Products Business Overview Table 125. Dechra Veterinary Products Pet Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Dechra Veterinary Products Pet Vaccine Product Portfolio Table 127. Dechra Veterinary Products Recent Development Table 128. Ceva Company Information Table 129. Ceva Business Overview Table 130. Ceva Pet Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Ceva Pet Vaccine Product Portfolio Table 132. Ceva Recent Development Table 133. Boehringer Ingelheim Company Information Table 134. Boehringer Ingelheim Business Overview Table 135. Boehringer Ingelheim Pet Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. Boehringer Ingelheim Pet Vaccine Product Portfolio Table 137. Boehringer Ingelheim Recent Development Table 138. Animalcare Group Company Information Table 139. Animalcare Group Business Overview Table 140. Animalcare Group Pet Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 141. Animalcare Group Pet Vaccine Product Portfolio Table 142. Animalcare Group Recent Development Table 143. North America Pet Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 144. North America Pet Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 145. North America Pet Vaccine Sales by Type (2021-2026) & (K Units) Table 146. North America Pet Vaccine Sales by Type (2027-2032) & (K Units) Table 147. North America Pet Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 148. North America Pet Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 149. North America Pet Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 150. North America Pet Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 151. North America Pet Vaccine Sales by Application (2021-2026) & (K Units) Table 152. North America Pet Vaccine Sales by Application (2027-2032) & (K Units) Table 153. North America Pet Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 154. North America Pet Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 155. North America Pet Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 156. North America Pet Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 157. North America Pet Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 158. North America Pet Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 159. North America Pet Vaccine Sales by Country (2021-2026) & (K Units) Table 160. North America Pet Vaccine Sales by Country (2027-2032) & (K Units) Table 161. North America Pet Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 162. North America Pet Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 163. United States Pet Vaccine Revenue (2021-2032) & (US$ Million) Table 164. Canada Pet Vaccine Revenue (2021-2032) & (US$ Million) Table 165. Europe Pet Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 166. Europe Pet Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 167. Europe Pet Vaccine Sales by Type (2021-2026) & (K Units) Table 168. Europe Pet Vaccine Sales by Type (2027-2032) & (K Units) Table 169. Europe Pet Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 170. Europe Pet Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 171. Europe Pet Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 172. Europe Pet Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 173. Europe Pet Vaccine Sales by Application (2021-2026) & (K Units) Table 174. Europe Pet Vaccine Sales by Application (2027-2032) & (K Units) Table 175. Europe Pet Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 176. Europe Pet Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 177. Europe Pet Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 178. Europe Pet Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 179. Europe Pet Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 180. Europe Pet Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 181. Europe Pet Vaccine Sales by Country (2021-2026) & (K Units) Table 182. Europe Pet Vaccine Sales by Country (2027-2032) & (K Units) Table 183. Europe Pet Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 184. Europe Pet Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 185. Germany Pet Vaccine Revenue (2021-2032) & (US$ Million) Table 186. France Pet Vaccine Revenue (2021-2032) & (US$ Million) Table 187. U.K. Pet Vaccine Revenue (2021-2032) & (US$ Million) Table 188. Italy Pet Vaccine Revenue (2021-2032) & (US$ Million) Table 189. Netherlands Pet Vaccine Revenue (2021-2032) & (US$ Million) Table 190. China Pet Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 191. China Pet Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 192. China Pet Vaccine Sales by Type (2021-2026) & (K Units) Table 193. China Pet Vaccine Sales by Type (2027-2032) & (K Units) Table 194. China Pet Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 195. China Pet Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 196. China Pet Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 197. China Pet Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 198. China Pet Vaccine Sales by Application (2021-2026) & (K Units) Table 199. China Pet Vaccine Sales by Application (2027-2032) & (K Units) Table 200. China Pet Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 201. China Pet Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 202. Asia Pet Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 203. Asia Pet Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 204. Asia Pet Vaccine Sales by Type (2021-2026) & (K Units) Table 205. Asia Pet Vaccine Sales by Type (2027-2032) & (K Units) Table 206. Asia Pet Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 207. Asia Pet Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 208. Asia Pet Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 209. Asia Pet Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 210. Asia Pet Vaccine Sales by Application (2021-2026) & (K Units) Table 211. Asia Pet Vaccine Sales by Application (2027-2032) & (K Units) Table 212. Asia Pet Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 213. Asia Pet Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 214. Asia Pet Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 215. Asia Pet Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 216. Asia Pet Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 217. Asia Pet Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 218. Asia Pet Vaccine Sales by Country (2021-2026) & (K Units) Table 219. Asia Pet Vaccine Sales by Country (2027-2032) & (K Units) Table 220. Asia Pet Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 221. Asia Pet Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 222. Japan Pet Vaccine Revenue (2021-2032) & (US$ Million) Table 223. South Korea Pet Vaccine Revenue (2021-2032) & (US$ Million) Table 224. India Pet Vaccine Revenue (2021-2032) & (US$ Million) Table 225. Australia Pet Vaccine Revenue (2021-2032) & (US$ Million) Table 226. China Taiwan Pet Vaccine Revenue (2021-2032) & (US$ Million) Table 227. Southeast Asia Pet Vaccine Revenue (2021-2032) & (US$ Million) Table 228. SAMEA Pet Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 229. SAMEA Pet Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 230. SAMEA Pet Vaccine Sales by Type (2021-2026) & (K Units) Table 231. SAMEA Pet Vaccine Sales by Type (2027-2032) & (K Units) Table 232. SAMEA Pet Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 233. SAMEA Pet Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 234. SAMEA Pet Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 235. SAMEA Pet Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 236. SAMEA Pet Vaccine Sales by Application (2021-2026) & (K Units) Table 237. SAMEA Pet Vaccine Sales by Application (2027-2032) & (K Units) Table 238. SAMEA Pet Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 239. SAMEA Pet Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 240. SAMEA Pet Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 241. SAMEA Pet Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 242. SAMEA Pet Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 243. SAMEA Pet Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 244. SAMEA Pet Vaccine Sales by Country (2021-2026) & (K Units) Table 245. SAMEA Pet Vaccine Sales by Country (2027-2032) & (K Units) Table 246. SAMEA Pet Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 247. SAMEA Pet Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 248. Brazil Pet Vaccine Revenue (2021-2032) & (US$ Million) Table 249. Argentina Pet Vaccine Revenue (2021-2032) & (US$ Million) Table 250. Chile Pet Vaccine Revenue (2021-2032) & (US$ Million) Table 251. Colombia Pet Vaccine Revenue (2021-2032) & (US$ Million) Table 252. Peru Pet Vaccine Revenue (2021-2032) & (US$ Million) Table 253. Saudi Arabia Pet Vaccine Revenue (2021-2032) & (US$ Million) Table 254. Israel Pet Vaccine Revenue (2021-2032) & (US$ Million) Table 255. UAE Pet Vaccine Revenue (2021-2032) & (US$ Million) Table 256. Turkey Pet Vaccine Revenue (2021-2032) & (US$ Million) Table 257. Iran Pet Vaccine Revenue (2021-2032) & (US$ Million) Table 258. Egypt Pet Vaccine Revenue (2021-2032) & (US$ Million) Table 259. Key Raw Materials Table 260. Raw Materials Key Suppliers Table 261. Pet Vaccine Distributors List Table 262. Pet Vaccine Customers List Table 263. Research Programs/Design for This Report Table 264. Authors List of This Report Table 265. Secondary Sources Table 266. Primary Sources List of Figures Figure 1. Pet Vaccine Image Figure 2. Global Pet Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pet Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Nasal Administration Image Figure 5. Injection Image Figure 6. Other Image Figure 7. Global Pet Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Pet Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 9. Cat Image Figure 10. Dog Image Figure 11. Other Image Figure 12. Global Pet Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Pet Vaccine Revenue (2021-2032) & (US$ Million) Figure 14. Global Pet Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Pet Vaccine Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Pet Vaccine Revenue Market Share by Region (2021-2032) Figure 17. Global Pet Vaccine Sales (2021-2032) & (K Units) Figure 18. Global Pet Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 19. Global Pet Vaccine Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Pet Vaccine Sales YoY (2021-2032) & (K Units) Figure 21. Europe Pet Vaccine Sales YoY (2021-2032) & (K Units) Figure 22. China Pet Vaccine Sales YoY (2021-2032) & (K Units) Figure 23. Asia (Excluding China) Pet Vaccine Sales YoY (2021-2032) & (K Units) Figure 24. South America, Middle East and Africa Pet Vaccine Sales YoY (2021-2032) & (K Units) Figure 25. Global Pet Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Pet Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Pet Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Pet Vaccine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Pet Vaccine Revenue Market Share by Type (2021-2032) Figure 31. Global Pet Vaccine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global Pet Vaccine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Pet Vaccine Sales Market Share by Type (2021-2032) Figure 34. Global Pet Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Pet Vaccine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Pet Vaccine Revenue Market Share by Application (2021-2032) Figure 37. Global Pet Vaccine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global Pet Vaccine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Pet Vaccine Sales Market Share by Application (2021-2032) Figure 40. North America Pet Vaccine Revenue Share by Type (2021-2032) Figure 41. North America Pet Vaccine Sales Share by Type (2021-2032) Figure 42. North America Pet Vaccine Revenue Share by Application (2021-2032) Figure 43. North America Pet Vaccine Sales Share by Application (2021-2032) Figure 44. North America Pet Vaccine Revenue Share by Country (2021-2032) Figure 45. North America Pet Vaccine Sales Share by Country (2021-2032) Figure 46. Europe Pet Vaccine Revenue Share by Type (2021-2032) Figure 47. Europe Pet Vaccine Sales Share by Type (2021-2032) Figure 48. Europe Pet Vaccine Revenue Share by Application (2021-2032) Figure 49. Europe Pet Vaccine Sales Share by Application (2021-2032) Figure 50. Europe Pet Vaccine Revenue Share by Country (2021-2032) Figure 51. Europe Pet Vaccine Sales Share by Country (2021-2032) Figure 52. China Pet Vaccine Revenue Share by Type (2021-2032) Figure 53. China Pet Vaccine Sales Share by Type (2021-2032) Figure 54. China Pet Vaccine Revenue Share by Application (2021-2032) Figure 55. China Pet Vaccine Sales Share by Application (2021-2032) Figure 56. Asia Pet Vaccine Revenue Share by Type (2021-2032) Figure 57. Asia Pet Vaccine Sales Share by Type (2021-2032) Figure 58. Asia Pet Vaccine Revenue Share by Application (2021-2032) Figure 59. Asia Pet Vaccine Sales Share by Application (2021-2032) Figure 60. Asia Pet Vaccine Revenue Share by Country (2021-2032) Figure 61. Asia Pet Vaccine Sales Share by Country (2021-2032) Figure 62. SAMEA Pet Vaccine Revenue Share by Type (2021-2032) Figure 63. SAMEA Pet Vaccine Sales Share by Type (2021-2032) Figure 64. SAMEA Pet Vaccine Revenue Share by Application (2021-2032) Figure 65. SAMEA Pet Vaccine Sales Share by Application (2021-2032) Figure 66. SAMEA Pet Vaccine Revenue Share by Country (2021-2032) Figure 67. SAMEA Pet Vaccine Sales Share by Country (2021-2032) Figure 68. Pet Vaccine Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Pet Vaccine Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Nasal Administration
  • Injection
  • Other
Applications
  • Cat
  • Dog
  • Other
Companies covered
  • CAHIC
  • Zoetis
  • Ringpu
  • Merck Animal Health
  • Keqian Biology
  • Jinyu Group
  • Virbac
  • Vetoquinol
  • Parnell
  • Ouro Fino Saude
  • Meiji
  • Kyoritsu Seiyaku
  • Elanco Animal Health
  • Dechra Veterinary Products
  • Ceva
  • Boehringer Ingelheim
  • Animalcare Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pet Vaccine Market by Type
  3. 1.2.1 Global Pet Vaccine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Nasal Administration
  5. 1.2.3 Injection
  6. 1.2.4 Other
  7. 1.3 Pet Vaccine Market by Application
  8. 1.3.1 Global Pet Vaccine Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Cat
  10. 1.3.3 Dog
  11. 1.3.4 Other
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Pet Vaccine Market Dynamics
  1. 2.1 Pet Vaccine Industry Trends
  2. 2.2 Pet Vaccine Industry Drivers
  3. 2.3 Pet Vaccine Industry Opportunities and Challenges
  4. 2.4 Pet Vaccine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Pet Vaccine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Pet Vaccine Revenue by Region
  3. 3.2.1 Global Pet Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Pet Vaccine Revenue by Region (2021-2026)
  5. 3.2.3 Global Pet Vaccine Revenue by Region (2027-2032)
  6. 3.2.4 Global Pet Vaccine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Pet Vaccine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Pet Vaccine Sales by Region
  9. 3.4.1 Global Pet Vaccine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Pet Vaccine Sales by Region (2021-2026)
  11. 3.4.3 Global Pet Vaccine Sales by Region (2027-2032)
  12. 3.4.4 Global Pet Vaccine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Pet Vaccine Revenue by Manufacturers
  2. 4.1.1 Global Pet Vaccine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Pet Vaccine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Pet Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Pet Vaccine Sales by Manufacturers
  6. 4.2.1 Global Pet Vaccine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Pet Vaccine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Pet Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Pet Vaccine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Pet Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Pet Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Pet Vaccine Manufacturers, Product Type & Application
  13. 4.7 Global Pet Vaccine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Pet Vaccine Market CR5 and HHI
  16. 4.8.2 2025 Pet Vaccine Tier 1, Tier 2, and Tier 3
5 Pet Vaccine Market by Type
  1. 5.1 Global Pet Vaccine Revenue by Type
  2. 5.1.1 Global Pet Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Pet Vaccine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Pet Vaccine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Pet Vaccine Sales by Type
  6. 5.2.1 Global Pet Vaccine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pet Vaccine Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Pet Vaccine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Pet Vaccine Price by Type
6 Pet Vaccine Market by Application
  1. 6.1 Global Pet Vaccine Revenue by Application
  2. 6.1.1 Global Pet Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Pet Vaccine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Pet Vaccine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Pet Vaccine Sales by Application
  6. 6.2.1 Global Pet Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Pet Vaccine Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Pet Vaccine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Pet Vaccine Price by Application
7 Company Profiles
  1. 7.1 CAHIC
  2. 7.1.1 CAHIC Company Information
  3. 7.1.2 CAHIC Business Overview
  4. 7.1.3 CAHIC Pet Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 CAHIC Pet Vaccine Product Portfolio
  6. 7.1.5 CAHIC Recent Developments
  7. 7.2 Zoetis
  8. 7.2.1 Zoetis Company Information
  9. 7.2.2 Zoetis Business Overview
  10. 7.2.3 Zoetis Pet Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Zoetis Pet Vaccine Product Portfolio
  12. 7.2.5 Zoetis Recent Developments
  13. 7.3 Ringpu
  14. 7.3.1 Ringpu Company Information
  15. 7.3.2 Ringpu Business Overview
  16. 7.3.3 Ringpu Pet Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Ringpu Pet Vaccine Product Portfolio
  18. 7.3.5 Ringpu Recent Developments
  19. 7.4 Merck Animal Health
  20. 7.4.1 Merck Animal Health Company Information
  21. 7.4.2 Merck Animal Health Business Overview
  22. 7.4.3 Merck Animal Health Pet Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Merck Animal Health Pet Vaccine Product Portfolio
  24. 7.4.5 Merck Animal Health Recent Developments
  25. 7.5 Keqian Biology
  26. 7.5.1 Keqian Biology Company Information
  27. 7.5.2 Keqian Biology Business Overview
  28. 7.5.3 Keqian Biology Pet Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Keqian Biology Pet Vaccine Product Portfolio
  30. 7.5.5 Keqian Biology Recent Developments
  31. 7.6 Jinyu Group
  32. 7.6.1 Jinyu Group Company Information
  33. 7.6.2 Jinyu Group Business Overview
  34. 7.6.3 Jinyu Group Pet Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Jinyu Group Pet Vaccine Product Portfolio
  36. 7.6.5 Jinyu Group Recent Developments
  37. 7.7 Virbac
  38. 7.7.1 Virbac Company Information
  39. 7.7.2 Virbac Business Overview
  40. 7.7.3 Virbac Pet Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Virbac Pet Vaccine Product Portfolio
  42. 7.7.5 Virbac Recent Developments
  43. 7.8 Vetoquinol
  44. 7.8.1 Vetoquinol Company Information
  45. 7.8.2 Vetoquinol Business Overview
  46. 7.8.3 Vetoquinol Pet Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Vetoquinol Pet Vaccine Product Portfolio
  48. 7.8.5 Vetoquinol Recent Developments
  49. 7.9 Parnell
  50. 7.9.1 Parnell Company Information
  51. 7.9.2 Parnell Business Overview
  52. 7.9.3 Parnell Pet Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Parnell Pet Vaccine Product Portfolio
  54. 7.9.5 Parnell Recent Developments
  55. 7.10 Ouro Fino Saude
  56. 7.10.1 Ouro Fino Saude Company Information
  57. 7.10.2 Ouro Fino Saude Business Overview
  58. 7.10.3 Ouro Fino Saude Pet Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Ouro Fino Saude Pet Vaccine Product Portfolio
  60. 7.10.5 Ouro Fino Saude Recent Developments
  61. 7.11 Meiji
  62. 7.11.1 Meiji Company Information
  63. 7.11.2 Meiji Business Overview
  64. 7.11.3 Meiji Pet Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Meiji Pet Vaccine Product Portfolio
  66. 7.11.5 Meiji Recent Developments
  67. 7.12 Kyoritsu Seiyaku
  68. 7.12.1 Kyoritsu Seiyaku Company Information
  69. 7.12.2 Kyoritsu Seiyaku Business Overview
  70. 7.12.3 Kyoritsu Seiyaku Pet Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Kyoritsu Seiyaku Pet Vaccine Product Portfolio
  72. 7.12.5 Kyoritsu Seiyaku Recent Developments
  73. 7.13 Elanco Animal Health
  74. 7.13.1 Elanco Animal Health Company Information
  75. 7.13.2 Elanco Animal Health Business Overview
  76. 7.13.3 Elanco Animal Health Pet Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Elanco Animal Health Pet Vaccine Product Portfolio
  78. 7.13.5 Elanco Animal Health Recent Developments
  79. 7.14 Dechra Veterinary Products
  80. 7.14.1 Dechra Veterinary Products Company Information
  81. 7.14.2 Dechra Veterinary Products Business Overview
  82. 7.14.3 Dechra Veterinary Products Pet Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Dechra Veterinary Products Pet Vaccine Product Portfolio
  84. 7.14.5 Dechra Veterinary Products Recent Developments
  85. 7.15 Ceva
  86. 7.15.1 Ceva Company Information
  87. 7.15.2 Ceva Business Overview
  88. 7.15.3 Ceva Pet Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Ceva Pet Vaccine Product Portfolio
  90. 7.15.5 Ceva Recent Developments
  91. 7.16 Boehringer Ingelheim
  92. 7.16.1 Boehringer Ingelheim Company Information
  93. 7.16.2 Boehringer Ingelheim Business Overview
  94. 7.16.3 Boehringer Ingelheim Pet Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Boehringer Ingelheim Pet Vaccine Product Portfolio
  96. 7.16.5 Boehringer Ingelheim Recent Developments
  97. 7.17 Animalcare Group
  98. 7.17.1 Animalcare Group Company Information
  99. 7.17.2 Animalcare Group Business Overview
  100. 7.17.3 Animalcare Group Pet Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Animalcare Group Pet Vaccine Product Portfolio
  102. 7.17.5 Animalcare Group Recent Developments
8 North America
  1. 8.1 North America Pet Vaccine Market Size by Type
  2. 8.1.1 North America Pet Vaccine Revenue by Type (2021-2032)
  3. 8.1.2 North America Pet Vaccine Sales by Type (2021-2032)
  4. 8.1.3 North America Pet Vaccine Price by Type (2021-2032)
  5. 8.2 North America Pet Vaccine Market Size by Application
  6. 8.2.1 North America Pet Vaccine Revenue by Application (2021-2032)
  7. 8.2.2 North America Pet Vaccine Sales by Application (2021-2032)
  8. 8.2.3 North America Pet Vaccine Price by Application (2021-2032)
  9. 8.3 North America Pet Vaccine Market Size by Country
  10. 8.3.1 North America Pet Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Pet Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Pet Vaccine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Pet Vaccine Market Size by Type
  2. 9.1.1 Europe Pet Vaccine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Pet Vaccine Sales by Type (2021-2032)
  4. 9.1.3 Europe Pet Vaccine Price by Type (2021-2032)
  5. 9.2 Europe Pet Vaccine Market Size by Application
  6. 9.2.1 Europe Pet Vaccine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Pet Vaccine Sales by Application (2021-2032)
  8. 9.2.3 Europe Pet Vaccine Price by Application (2021-2032)
  9. 9.3 Europe Pet Vaccine Market Size by Country
  10. 9.3.1 Europe Pet Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Pet Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Pet Vaccine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Pet Vaccine Market Size by Type
  2. 10.1.1 China Pet Vaccine Revenue by Type (2021-2032)
  3. 10.1.2 China Pet Vaccine Sales by Type (2021-2032)
  4. 10.1.3 China Pet Vaccine Price by Type (2021-2032)
  5. 10.2 China Pet Vaccine Market Size by Application
  6. 10.2.1 China Pet Vaccine Revenue by Application (2021-2032)
  7. 10.2.2 China Pet Vaccine Sales by Application (2021-2032)
  8. 10.2.3 China Pet Vaccine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Pet Vaccine Market Size by Type
  2. 11.1.1 Asia Pet Vaccine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Pet Vaccine Sales by Type (2021-2032)
  4. 11.1.3 Asia Pet Vaccine Price by Type (2021-2032)
  5. 11.2 Asia Pet Vaccine Market Size by Application
  6. 11.2.1 Asia Pet Vaccine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Pet Vaccine Sales by Application (2021-2032)
  8. 11.2.3 Asia Pet Vaccine Price by Application (2021-2032)
  9. 11.3 Asia Pet Vaccine Market Size by Country
  10. 11.3.1 Asia Pet Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Pet Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Pet Vaccine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Pet Vaccine Market Size by Type
  2. 12.1.1 SAMEA Pet Vaccine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Pet Vaccine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Pet Vaccine Price by Type (2021-2032)
  5. 12.2 SAMEA Pet Vaccine Market Size by Application
  6. 12.2.1 SAMEA Pet Vaccine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Pet Vaccine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Pet Vaccine Price by Application (2021-2032)
  9. 12.3 SAMEA Pet Vaccine Market Size by Country
  10. 12.3.1 SAMEA Pet Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Pet Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Pet Vaccine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Pet Vaccine Value Chain Analysis
  2. 13.1.1 Pet Vaccine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Pet Vaccine Production Mode & Process
  6. 13.2 Pet Vaccine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Pet Vaccine Distributors
  9. 13.2.3 Pet Vaccine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst